azacitidine has been researched along with Anemia, Aplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dornaus, S; Frietsch, JJ; Hochhaus, A; Kunert, C; La Rosée, P; Neumann, T; Sayer, HG; Schmidt, V; Scholl, S | 1 |
| Schleiffenbaum, BE | 1 |
| Gao, L; Kang, HY; Li, MY; Wang, CB; Wang, LL; Wang, W; Wang, XR; Yu, L | 1 |
| Bouffioux, B; Courtin, C; Janssens, P; Ngendahayo, P; Saint-Remy, A; Voogeleer, MN | 1 |
1 review(s) available for azacitidine and Anemia, Aplastic
| Article | Year |
|---|---|
Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.
Topics: Adult; Aged; Anemia, Aplastic; Antimetabolites, Antineoplastic; Autoimmunity; Azacitidine; Bone Marrow; Bone Marrow Diseases; Bone Marrow Failure Disorders; Diagnosis, Differential; Female; Hemoglobinuria, Paroxysmal; Humans; Inflammation; Male; Middle Aged; Myelodysplastic Syndromes; Paraneoplastic Syndromes; Treatment Outcome | 2014 |
3 other study(ies) available for azacitidine and Anemia, Aplastic
| Article | Year |
|---|---|
[CME myelodysplasia - a frequent hematologic neoplasia in the elderly].
Topics: Aged, 80 and over; Anemia, Aplastic; Azacitidine; Bone Marrow; Bone Marrow Examination; Cell Proliferation; Cell Transformation, Neoplastic; Decitabine; Diagnosis, Differential; Disease Progression; Hematopoiesis; Humans; Lenalidomide; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Prognosis; Thalidomide | 2014 |
[Clinical Significance of ID4 Gene Mehtylation in Demethylation-Treated MDS Cell Line and 2 MDS Patients].
Topics: Anemia, Aplastic; Azacitidine; Bone Marrow; Cell Line; Decitabine; DNA Methylation; Gene Expression; Genes, Tumor Suppressor; Humans; Inhibitor of Differentiation Proteins; Myelodysplastic Syndromes; Polymerase Chain Reaction; Promoter Regions, Genetic | 2015 |
[Vesiculobullous Sweet's syndrome].
Topics: Abdomen; Aged; Anemia, Aplastic; Antimetabolites, Antineoplastic; Azacitidine; Fatal Outcome; Humans; Immunocompromised Host; Injections, Subcutaneous; Male; Shock, Septic; Sweet Syndrome | 2017 |